ClinicalTrials.Veeva

Menu

MACE and PE in Elective Primary TKA & THA

U

University of Thessaly

Status

Completed

Conditions

Pulmonary Embolism
Death
Stroke
Cardiovascular Complication
Transient Ischemic Attack

Study type

Observational

Funder types

Other

Identifiers

NCT05116280
MACE & PE in TJA

Details and patient eligibility

About

This study ought to identify the occurence of the major adverse cardiovascular events (MACE) and the pumonary emoblism (PE) in patients undergoing elective primary THA & TKA

Full description

The study included 220 consecutive patients undergoing elective primary THA & TKA from January 2018 to December 2018. The occcurence of major adverse cardiovascular events (MACE) and the pumonary emoblism (PE) were recorder. Under the term MACE the following were included; non fatal cardiac arrest acute myocardial infraction congestive cardiac failure cardiac arrhythmia agnina stroke cardiovascular death cerebrovascular death

Enrollment

200 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All consecutive patients age 18 years or older, with a diagnosis of primary osteoarthritis of the hip or knee, who underwent elective, primary, unilateral TKA or THA.

Exclusion criteria

  • previous TKA or THA within 3 months
  • Revision surgery
  • Surgical procedures related to a previous complication
  • ASA PS IV
  • recent history (6 months) of unstable acute coronary syndrome or decompensated heart failure

Trial design

200 participants in 1 patient group

TJA
Description:
patients with primary osteoarthritis of the knee and hip who underwent elective primary total hip and total knee arthroplasty. MACE and pulmonary embolism were recorded

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems